| Antimicrobial Agent | Susceptibility Profile | Clinical Interpretation |
|---|---|---|
| Amikacin | Sensitive | 4 |
| Amoxicillin/Clavulanic acid | Intermediate | 16 |
| Cefepime | Resistant | >=32 |
| Ceftriaxone | Resistant | >=64 |
| Cefuroxime | Resistant | >=64 |
| Ciprofloxacin | Intermediate | >=4 |
| Colistin | Sensitive | <=0.5 |
| Ertapenem | Sensitive | 0.25 |
| Gentamicin | Resistant | <=1 |
| Imipenem | Sensitive | <=0.25 |
| Meropenem | Sensitive | <=0.25 |
| Piperacillin/Tazobactam | Resistant | 32 |
| Trimethoprim/Sulfamethoxazole | <=20 |
| Resistant Gene Track | Detection Methodology | NCBI Genome Accession |
|---|---|---|
| oqxA | PCR | |
| oqxB | PCR |